AAAAAA
Results: 26-40/40
Authors:
FUSTER E
MUNOZ MC
GARCIACORET MJ
FUSTER CA
LLUCH A
GARCIAVILANOVA A
DAVILA D
COMAS AGV
TODOLI J
CHECA F
TRULLENQUE R
Citation: E. Fuster et al., THE RELATIONSHIP BETWEEN THE TUMOR STAGING (1987) AND HORMONE-RECEPTOR STATUS IN FEMALE BREAST-CANCER, British Journal of Surgery, 82, 1995, pp. 19-20
Authors:
GARCIACONDE J
BENET I
ARBONA C
SOLANO C
MARUGAN I
MARTINGAITERO MJ
VERCHER J
LLUCH A
Citation: J. Garciaconde et al., RELATIONSHIP BETWEEN STEM-CELL IMMUNOPHENOTYPE, EARLY AND LATE HEMATOPOIETIC RECOVERY IN PERIPHERAL-BLOOD STEM-CELL TRANSPLANT (PBSCT) IN BREAST-CANCER PATIENTS, Blood, 86(10), 1995, pp. 3919-3919
Authors:
HORNEDO J
SOLA C
SOLANO C
LOPEZ JJ
LLUCH A
GARCIACONDE J
CORTESFUNES H
Citation: J. Hornedo et al., MULTICENTER STUDY ON THE EFFICACY OF FILGRASTIM IN OBTAINING CD34-CANCER PATIENTS (PTS) PREVIOUSLY TREATED WITH CHEMOTHERAPY( CELLS IN BREAST), Blood, 86(10), 1995, pp. 3923-3923
Authors:
MONTERO MC
VALDIVIA ML
CARVAJAL E
MONTANO A
BUENESTADO C
LLUCH A
ATIENZA M
Citation: Mc. Montero et al., ECONOMIC-STUDY OF NEUTROPENIA INDUCED BY MYELOTOXIC CHEMOTHERAPY, Pharmacy world & science, 16(4), 1994, pp. 187-192
Authors:
GARCIACONDE J
LLUCH A
MARTIN M
CASADO A
GERVASIO H
DEOLIVEIRA C
DEPABLO JL
GOROSTIAGA J
GIRON GC
CERVANTES A
MARTINEZ A
PEZOUS N
DELGADO FM
RUBIO ED
Citation: J. Garciaconde et al., PHASE-II TRIAL OF WEEKLY IV-VINORELBINE IN FIRST-LINE ADVANCED BREAST-CANCER CHEMOTHERAPY, Annals of oncology, 5(9), 1994, pp. 854-857
Authors:
MARTIN M
LLUCH A
CASADO A
SANTABARBARA P
ADROVER E
VALVERDE JJ
LOPEZMARTIN JA
RODRIGUEZLESCURE A
AZAGRA P
GARCIACONDE J
DIAZRUBIO E
Citation: M. Martin et al., CLINICAL ACTIVITY OF CHRONIC ORAL ETOPOSIDE IN PREVIOUSLY TREATED METASTATIC BREAST-CANCER, Journal of clinical oncology, 12(5), 1994, pp. 986-991
Authors:
VIZCARRA E
LLUCH A
CIBRIAN R
JARQUE F
GARCIACONDE J
Citation: E. Vizcarra et al., CA-15.3, CEA AND TPA TUMOR-MARKERS IN THE EARLY DIAGNOSIS OF BREAST-CANCER RELAPSE, Oncology, 51(6), 1994, pp. 491-496
Authors:
JARQUE F
LLUCH A
VIZCARRA E
MUNOZ M
ALBEROLA V
GARCIACONDE J
Citation: F. Jarque et al., QUANTITATIVE MONOCLONAL-ANTIBODY DETERMINATION OF ESTROGEN AND PROGESTERONE RECEPTORS IN HUMAN BREAST-CANCER - CORRELATION WITH THE RADIOLIGAND METHOD, Oncology, 51(5), 1994, pp. 435-439
Authors:
LLUCH A
AZAGRA P
CERVANTES A
MUNOZ M
ALBEROLA V
SANTABARBARA P
GARCIACONDE J
Citation: A. Lluch et al., PHASE-II TRIAL OF CISPLATIN AND ETOPOSIDE AS FIRST-LINE THERAPY IN METASTATIC BREAST-CARCINOMA, Oncology, 51(4), 1994, pp. 352-355
Authors:
BOLUFER P
MOLINA R
RUIZ A
HERNANDEZ M
VAZQUEZ C
LLUCH A
Citation: P. Bolufer et al., ESTRADIOL RECEPTORS IN COMBINATION WITH NEU OR MYC ONCOGENE AMPLIFICATIONS MIGHT DEFINE NEW SUBTYPES OF BREAST-CANCER, Clinica chimica acta, 229(1-2), 1994, pp. 107-122
Authors:
GARCIACONDE J
SOLANO C
ARBONA G
BENET I
MARUGAN I
TORMO M
LLUCH A
Citation: J. Garciaconde et al., HEMATOLOGICAL AND IMMUNOLOGICAL RECOVERY IN BREAST-CANCER PATIENTS AFTER HIGH-DOSE CHEMOTHERAPY AND HEMATOLOGICAL STEM-CELL REINFUSION, Blood, 84(10), 1994, pp. 10000208-10000208
Authors:
LLUCH A
SANCHEZBAEZA F
MESSEGUER A
Citation: A. Lluch et al., DIOXIRANES AS OXIDIZING-AGENTS IN ORGANIC-SYNTHESIS - AN ALTERNATIVE TO CONVENTIONAL REAGENTS, Anales de quimica, 89(1), 1993, pp. 133-134
Authors:
MARTIN M
CASADO A
LLUCH A
ADROVER E
DIAZRUBIO E
GARCIACONDE J
Citation: M. Martin et al., PRELIMINARY-RESULTS OF A PHASE-II TRIAL OF CHRONIC ORAL ETOPOSIDE IN BREAST-CANCER, Cancer treatment reviews, 19, 1993, pp. 47-52
Authors:
LLUCH A
MIQUEL V
Citation: A. Lluch et V. Miquel, COMPARING THE RELATIVE VOLUME WITH A REVOLUTION MANIFOLD AS A MODEL, Israel Journal of Mathematics, 84(3), 1993, pp. 385-401
Authors:
BOLUFER P
LLUCH A
MOLINA R
ALBEROLA V
VAZQUEZ C
PADILLA J
GARCIACONDE J
LLOPIS F
GUILLEM V
Citation: P. Bolufer et al., EPIDERMAL GROWTH-FACTOR IN HUMAN BREAST-CANCER, ENDOMETRIAL CARCINOMAAND LUNG-CANCER - ITS RELATIONSHIP TO EPIDERMAL GROWTH-FACTOR RECEPTOR, ESTRADIOL-RECEPTOR AND TUMOR TNM, Clinica chimica acta, 215(1), 1993, pp. 51-61